A major clinical trial has revealed that daraxonrasib, a new targeted oral therapy, could significantly improve outcomes for patients with advanced pancreatic cancer.
Civil society organisations, including the Treatment Action Campaign are urging Pres Cyril Ramaphosa to intervene with pharmaceutical company Gilead Sciences over access to lenacapavir, a twice-yearly HIV prevention injection being launched in SA.
On 2 June Business Day reported that Danish pharmaceutical company Novo Nordisk plans to request the High Court to prevent compounding pharmacy iDexis from manufacturing, advertising and distributing products containing semaglutide while regulatory investigations continue.
A new Alexander Forbes Health report warns that SA’s medical scheme industry is under increasing financial strain as healthcare costs, claims utilisation and the burden of chronic disease continue to rise.